Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination therapy consisting of "Bupleurum plus Dragon Bone and Oyster Shell Decoction" (a traditional Chinese herbal formula also known as Chai Hu Jia Long Gu Mu Li Tang) and the pharmaceutical antidepressant "sertraline." The herbal decoction is traditionally used in East Asian medicine to calm the spirit, harmonize Shao Yang, unblock the three Yang stages, move liver Qi, clear heat, subdue liver yang, dissolve phlegm, tonify righteous Qi, and promote mental well-being. Its ingredients include Bupleurum root (Chai Hu), Pinellia rhizome (Ban Xia), Poria (Fu Ling), Cinnamon twig (Gui Zhi), Chinese skullcap (Huang Qin), Jujube fruit (Da Zao), Ginger (Sheng Jiang), Ginseng root (Bai Shen or Dang Shen), Dragon's bone (Long Gu), Oyster shell (Mu Li), Rhubarb root/rhizome (Da Huang) among others[1][2][3][4][5][6]. Sertraline is a selective serotonin reuptake inhibitor antidepressant that increases synaptic serotonin levels by inhibiting its reuptake in the brain. This combination may be explored for synergistic effects on mood disorders or other neuropsychiatric conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bupleurum plus dragon bone and oyster shell decoction + sertraline.